The HUSERMET Project
the human serum metabolome in health and disease...


Alzheimer's Disease Study

Alzheimer's disease:

  • An estimated 25 million people worldwide suffer from dementia. In the UK alone, dementia affects over 800,000 people with an estimated annual cost of care of £6.1 billion
  • The incidence of dementia increases from 5% in the over 65s to 20% in the over 80s
  • Presently, no definitive diagnosis for Alzheimer's disease is accessible to clinicians
  • There is currently no cure for Alzheimer's disease but symptomatic treatments to improve memory and to reduce distressing symptoms are available

The differences between 'normal ageing', 'mild cognitive impairment' and 'dementia' remain unclear.

  • This highlights the need for sensitive and specific biological markers (biomarkers) that can aid early diagnosis and monitor the progression of Alzheimer's disease
  • Preferably, biomarkers which may be measured and monitored by relatively non-invasive techniques such as a blood test
  • At present no such biomarkers for Alzheimer's disease are available

The primary questions for the Alzheimer's disease study are:

  • Can biomarkers differentiate Alzheimer's disease from normal ageing?
  • Can a biomarker or biomarkers predict:
    • The progression of the disease from mild to moderate, and from moderate to severe?
    • The rate of and pattern of cognitive and functional decline?
    • The response to treatment, and therefore help to manage the condition appropriately?

Recruitment of subjects for this study was conducted with the assistance of:

[25 Sep. 2012]
HUSERMET represented at Metabomeeting 2012
[Read More...]
[30 Jun. 2011]
New Publication in Nature Protocols
[Read More...]
[23 Jan. 2010]
Manchester Researcher Appointed New 'Dementia Tsar'
[Read More...]
[04 Jan. 2010]
Newly Appointed Data Analyst
[Read More...]
[01 Nov. 2009]
Recruitment Finished
[Read More...]
[01 Aug. 2009]
Two New Publications
[Read More...]
[14 Apr. 2009]
Newly Appointed Research Technician
[Read More...]
[19 Nov. 2008]
New Project Manager
[Read More...]
[12 Sept. 2008]
HUSERMET Researchers Look to the Metabolome for Answers
[Read More...]
[07 Jul. 2008]
The University of Manchester and GSK Strike New Research Alliance
[Read More...]
[07 Jul. 2008]
Prof Doug Kell is the New Chief Executive for BBSRC
[Read More...]
[10 Dec. 2007]
The Maturing Field of Metabolomics is Taking Steps Toward Guiding Personalized Nutrition
[Read More...]
[24 Aug. 2007]
Free Health 'MOTs' in World's Biggest Male Ageing Study
[Read More...]
[20 Feb. 2007]
Newly Appointed Bioanalytical Scientist for the HUSERMET Project
[Read More...]